Mark Slack, VP Academic Partnerships, is responsible for the establishment and execution of Evotec’s academic BRIDGE activities. Through his EIR role, Mark works closely with TTOs, leading academics and investors to identify and develop novel drug discovery opportunities to develop these through the preclinical drug discovery cascade, through to spinout. Through his 20 years of drug discovery accrued within Evotec and pharma, Mark provides operational guidance to help develop projects to maximize their potential and build a sustainable investment portfolio.
Mark Slack. Ph.D.
VP Academic Partnerships, Evotec